65 Yaş Üstü Osteoporoz Hastalarında Denosumab ve Zoledronik Asit’in Yan Etkilerinin Karşılaştırılması

65 Yaş Üstü Osteoporoz Hastalarında Denosumab ve Zoledronik Asit’in Yan Etkilerinin Karşılaştırılması

Amaç: Osteoporoz tedavisi alan hastalarda, zoledronik asit ve denosumab kullanım oranları ile bu iki ilacın yan etkilerini karşılaştırmayı amaçladık. Gereç ve Yöntem: Çalışmamızda Ocak 2016-Aralık 2017 tarihleri arasında başvuran hastaların dosyaları taranarak, osteoporoz tanısıyla zoledronik asit...

Full description

Bibliographic Details
Main Authors:	Rabia Bağ Soytaş, Suna Avcı, Hakan Yavuzer, Serdar Özkök, Alper Döventaş, Deniz Suna Erdinçler
Format:	Article
Language:	English
Published:	Selcuk University Press 2021-06-01
Series:	Genel Tıp Dergisi
Subjects:	geriatric zoledronic acid denosumab side effect geriatri zoledronik asit yan etki
Online Access:	https://dergipark.org.tr/tr/download/article-file/1851290

Similar Items

Comparison of antiresorptive agents in the treatment of osteoporosis in older adults
by: Zeynel Abidin Öztürk, et al.
Published: (2022-09-01)

Zoledronik asit osteoporozlu β-talasemi hastalarında kemik mineral yoğunluğunu arttırır: Bir vaka kontrol çalışması
by: Mehtap EVRAN OLGUN, et al.
Published: (2019-09-01)

Zoledronik Asidin Meme Kanseri Alt Tiplerinde Terapötik Etkisinin Değerlendirilmesi
by: Gamze Güney Eskiler, et al.
Published: (2019-03-01)

Randomized Double-Blind Comparative Study of First Global Denosumab Biosimilar in Oncology
by: Prasad Apsangikar, et al.
Published: (2022-04-01)

A recurrent giant cell tumor of bone treated with denosumab
by: Nicola Stadler, et al.
Published: (2015-02-01)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
by: Jarred Strickling, et al.
Published: (2019-04-01)

Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study
by: Ji-Yeon Kang, et al.
Published: (2023-06-01)

Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study
by: Tzai-Chiu Yu, et al.
Published: (2024-12-01)

Torus palatinus osteonecrosis: A hitherto unreported complication of long-term Denosumab use
by: Kendal L. Weger, MD, et al.
Published: (2025-01-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study
by: Kyoung Min Kim, et al.
Published: (2024-12-01)

Problems in patient management and the impact of osteoporosis therapy on the incidence of clinical infection
by: O. M. Lesnyak, et al.
Published: (2021-07-01)

Denosumab is the first gene engineered agent for the treatment of osteoporosis
by: O A Nikitinskaya, et al.
Published: (2012-09-01)

Denosumab Treatment Improved Health‐Related Quality of Life in Osteoporosis: A Prospective Cohort Study
by: Shinya Hayashi, et al.
Published: (2019-07-01)

Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling
by: Lei Shangguan, et al.
Published: (2024-12-01)

Denosumab's Therapeutic Effect for Future Osteosarcopenia Therapy : A Systematic Review and Meta-Analysis
by: I Gusti Putu Suka Aryana, et al.
Published: (2023-03-01)

Denosumab for Breast Cancer with Bone Metastases-Induced Hypercalcemia Complicated with Acute Renal Failure
by: Chen-Yu Kuo, et al.
Published: (2015-06-01)

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
by: Aysun Seker, et al.
Published: (2025-01-01)

Novel injectable composite incorporating denosumab promotes bone regeneration via bone homeostasis regulation
by: Guang Yang, et al.
Published: (2024-12-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)

Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
by: Toshinori Hirai, et al.
Published: (2024-09-01)

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)
by: Christian Meier, et al.
Published: (2017-08-01)

Cancer treatment-induced bone loss
by: Yong Jun Choi
Published: (2024-09-01)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
by: Alexander Upfill‐Brown, et al.
Published: (2019-10-01)

Correction: Efficacy of Denosumab in the Treatment of Postmenopausal Osteoporosis: One-year Follow-up, Single Center Study
by: İsmail Tunçekin, et al.
Published: (2023-12-01)

Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy
by: Shunsuke Sawada, et al.
Published: (2023-10-01)

Ranking prognosis: Future perspective of RANK/RANKL in breast cancer
by: Ruby Dhar, et al.
Published: (2023-06-01)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Chuanjian Yuan, et al.
Published: (2023-06-01)

RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma
by: Hong‐Shuai Li, et al.
Published: (2023-05-01)

Denosumab Can Prevent Collapse in Patients with Early‐Stage Steroid‐Induced Osteonecrosis of the Femoral Head by Inhibiting Osteoclasts and Autophagy
by: Bo Liu, et al.
Published: (2023-01-01)

Periapical status in patients affected by osteoporosis: A retrospective clinical study
by: Erika Cadoni, et al.
Published: (2022-10-01)

Bisphosphonate-resistant hypercalcemia in a rare case of paraneoplastic PTH secretion
by: Anna Y. Groysman, et al.
Published: (2022-12-01)

Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
by: Jiaqi Wu, et al.
Published: (2018-08-01)

A rare case of sphenoid giant cell tumor: Case report & review of imaging features post short-term denosumab treatment
by: Farid Aassouani, MD, et al.
Published: (2022-10-01)

Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer
by: Hiroshi Masuda, et al.
Published: (2017-07-01)

USE OF DENOSUMAB IN GIANT-CELL TUMOR AT A PUBLIC HOSPITAL IN SOUTHERN BRAZIL: REPORT OF 13 CASES
by: Tamise da Silva Baptista, et al.
Published: (2019-01-01)

İç Hastalıkları Kliniğinde Yatarak İzlenen 65 Yaş ve Üzeri Genel Dahiliye Hastalarında Tanısal Dağılımın Araştırılması
by: Ahmet Nalbant, et al.
Published: (2013-12-01)

Infection Characteristics of Inpatients in Geriatrics Clinic
by: Serdar Özkök, et al.
Published: (2020-06-01)

Allopürinol'ün Neden Olduğu ve Seftriakson Tarafından Tetiklenen Yeni Bir DRESS Sendromu Olgusu
by: Muhammet Kızmaz, et al.
Published: (2019-06-01)